BioSpace News Archive

Haleigh’s Hope®, a high quality, whole-plant hemp extract containing naturally occurring cannabinoids, receives USDA organic certification for handling in addition to the previously awarded organic certification for crop.

Cibinetide, the lead compound of Araim Pharmaceuticals, Inc., a clinical stage biotechnology company pioneering the development of innate repair receptor activator platform technology, has recently been shown to improve the efficacy of endothelial colony forming cell transplantation to repair the vasculature in the retina.

Pharmacokinetic (PK)/pharmacodynamic (PD) study for PXL770 is expected to initiate 2Q 2019 with results anticipated 2H 2019

On February 12th, 2019, it was announced that Moberg Pharma AB has entered into agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest the entire commercial operation and that the Company intends to redeem its outstanding bonds 2016/2021 with ISIN SE0007953989 in connection with closing of the transaction.

As a high-end conference and event week specially launched concurrently with CPhI China, organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo.

Biotage’s 2018 Annual Report and Corporate Governance Report is available at: www.biotage.com.

Movement Orthopedics: A Great Alternative To The ER For Orthopedic Injuries

Funding to support expansion of ion channel screening capabilities and continued research into potential drugs for auto-immune diseases

Royalty Pharma and Arteaus Therapeutics announced that Arteaus has sold its royalty interest on future global net sales of Eli Lilly and Company’s Emgality, an anti-CGRP antibody for the prevention of migraine, to Royalty Pharma for $260 million.

TERN-101 Demonstrated Potency as an Agonist of FXR Nuclear Hormone Receptor